Moonrise Medical

moonrisemedical.com

Moonrise Medical develops AI-enabled ultrasound technology for the healthcare sector, specifically targeting peripheral vascular disease. The company offers an ultrasound-based device that aids in the diagnosis and evaluation of flow hemodynamics within the peripheral vascular system, with initial applications addressing peripheral artery disease (PAD) and diabetic foot ulcers (DFU). Moonrise Medical's technology is designed to facilitate early diagnosis as well as provide guidance for personalized treatment and interventions. It was founded in 2021 and is based in Oakville, Canada.